首页> 外文会议>International Mass Spectrometry Conference >MASS SPECTROMETRY EVALUATION OF CIRCULATING S100A8 AND S100A9 PROTEINS AS PROGNOSIS BIOMARKERS IN SEPSIS
【24h】

MASS SPECTROMETRY EVALUATION OF CIRCULATING S100A8 AND S100A9 PROTEINS AS PROGNOSIS BIOMARKERS IN SEPSIS

机译:循环S100A8和S100A9蛋白作为脓毒症预后生物标志物的质谱评价

获取原文

摘要

Sepsis causes one death every 5.2 seconds worldwide [1]. To achieve rapid patient care, prognostic markers are needed. Predictive value of S100A8/9 complex was recently highlighted with an ELISA[2]. However, antibody affinity to particular isoform is questionable. Our study has assessed the prognostic value of plasmatic S100A8 and S100A9 by combining intact protein mass spectrometry for isoform characterization and bottom-up quantification of total isoforms.
机译:败血症每5.2秒导致一次死亡[1]。为了实现快速的患者护理,需要预后标志物。最近用ELISA突出显示S100A8 / 9复合物的预测值[2]。然而,对特定同种型的抗体亲和力是可疑的。我们的研究通过将完整的蛋白质质谱法组合用于同种型的表征和自下而上的定量来评估等离子体S100a8和S100a9的预后值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号